Header Logo

Connection

RUSSELL BROADDUS to Hormone Antagonists

Back to Details
This is a "connection" page, showing publications RUSSELL BROADDUS has written about Hormone Antagonists.
RUSSELL BROADDUS
Connection Strength
0.080
Hormone Antagonists
  1. Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma. Cancer. 2009 May 01; 115(9):1867-74.
    View in: PubMed
    Score: 0.080
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.